In 2006, FzioMed launched Laresse Dermal Filler, the first ultra-smooth, non-permanent, synthetic filler created from the company's patented polymer science. Laresse represents a completely new class of filler for the correction of wrinkles and lines caused by sun exposure, aging and other factors.
After extensive characterization of cross-linked hyaluronic acid (HA) fillers, FzioMed designed Laresse from biocompatible polymers to have key gel properties that offer significant advantages over common fillers being used today. For example, Laresse is stable without chemical cross-linking, completely free of both bacterial and animal by-products, and smoother and easier to inject than HA fillers.
Richard Berg, Ph.D., FzioMed's Chief Scientific Officer, will present "Novel Synthetic Dermal Fillers" at AAMWC on March 24th. His talk will describe the rheological properties of commercialized cross-linked HA fillers and includes data demonstrating the broader versatility and advantages of FzioMed's polymer technology for formulating a family of improved dermal fillers, including Laresse.
"This presentation highlights FzioMed's approach of applying science to the rapidly evolving field of soft tissue augmentation," said John Krelle, FzioMed President & Chief Executive Officer.
Laresse Dermal Filler is an ultra-smooth, non-permanent, non-HA
gel composed of pure, absorbable medical polymers. Laresse is the
first non-permanent filler without many of the drawbacks of HA and
collagen fillers. No other filler offers the same features as
Laresse: non-permanent wrinkle correction, non-animal and